Veranex
Catheline Plaideau, PhD, currently serves as the Director of Commercial Strategy and Market Access at Veranex, a role undertaken since October 2022. Prior to this, Catheline held various positions at Veranex, including Senior Manager and Manager in the same field. Experience includes a consulting role in Corporate Project/Program Management at Alkermes and significant contributions at GSK, where responsibilities encompassed Pricing & Reimbursement Strategy and Digital Commercial Transformation. Earlier roles include Clinical Project Manager at BONE THERAPEUTICS S.A. and a PhD student at both de Duve Institute and AstraZeneca. Catheline’s education features a range of advanced credentials, including a PhD in Pharmaceutical and Biomedical Sciences and multiple certificates in health economics and drug development from prestigious institutions such as the Massachusetts Institute of Technology and Université libre de Bruxelles.
This person is not in any teams
This person is not in any offices
Veranex
7 followers
Veranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment across the four concept-to-commercialization pillars — engineering and design, regulatory, clinical, and market access.